81627Y0870-INSTI HIV-1/2 Test kits and INSTI Control Test kits

The New York City Department of Health and Mental Hygiene is seeking expressions of interest from firms that can legally supply INSTI® HIV‑1/HIV‑2 Rapid Antibody Test kits (product code 90‑1019) and the corresponding test controls (product code 90‑1031) on an as‑needed basis for a six‑year period. The agency has identified BioLytical Laboratories Inc. as the sole source manufacturer and wants vendors to submit an Expression of Interest by the due date. No quantity, pricing, or award mechanism is disclosed at this stage. • Supply of INSTI® HIV rapid test kits and controls for use in field services and STD clinics across NYC. • Six‑year anticipated contract (July 1 2027 – June 30 2033) with a total estimated procurement value of roughly $9.65 M. • Sole‑source justification – BioLytical is the exclusive manufacturer; the agency requires direct purchase from the vendor.